Get startedLog in
    Picture of Edding Genor group logo

    6998 — Edding Genor group News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapValue Trap
    All News

    Brief: Jhbp Cy Says Infliximab Got Approval From China's Nmpa For Treatment Of Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriasis, Among Others

    Picture of Edding Genor group logoEdding Genor group
    01/03/2022 05:46
    March 1 (Reuters) - Genor Biopharma Holdings Ltd  6998.HK :
    * INFLIXIMAB GOT APPROVAL FROM CHINA'S NMPA FOR TREATMENT OF
RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, PSORIASIS, AMONG
OTHERS


Further company coverage:  6998.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Edding Genor group

    See all news